US FDA Gene Therapy Review Reorg Draws Congressional Interest

gene therapy
The House Energy and Commerce Committee wants more information on CBER's new Office of Therapeutic Products. • Source: Shutterstock

More from Cell & Gene Therapies

More from Advanced Technologies